Hillsdale Investment Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.26M | Buy |
107,756
+39,700
| +58% | +$1.94M | 0.19% | 157 |
|
|
2025
Q1 | $3.47M | Buy |
68,056
+67,886
| +39,933% | +$3.46M | 0.18% | 154 |
|
|
2024
Q4 | $7.67K | Hold |
170
| – | – | ﹤0.01% | 509 |
|
|
2024
Q3 | $6.31K | Hold |
170
| – | – | ﹤0.01% | 562 |
|
|
2024
Q2 | $5.2K | Buy |
+170
| New | +$5.2K | ﹤0.01% | 559 |
|
|
2023
Q3 | – | Sell |
-37,237
| Closed | -$1.51M | – | 635 |
|
|
2023
Q2 | $1.51M | Sell |
37,237
-13,400
| -26% | -$545K | 0.14% | 180 |
|
|
2023
Q1 | $2.45M | Sell |
50,637
-47,700
| -49% | -$2.31M | 0.21% | 145 |
|
|
2022
Q4 | $3.75M | Sell |
98,337
-2,000
| -2% | -$76.3K | 0.32% | 119 |
|
|
2022
Q3 | $5.04M | Buy |
+100,337
| New | +$5.04M | 0.46% | 70 |
|
|
2018
Q3 | – | Sell |
-2,300
| Closed | -$78K | – | 534 |
|
|
2018
Q2 | $78K | Buy |
+2,300
| New | +$78K | 0.01% | 300 |
|